Gazyva

Gazyva uses and dosage

Gazyva (Obinutuzumab), is a prescription medicine used to treat specific hematologic malignancies, including chronic lymphocytic leukemia and follicular lymphoma. As a monoclonal antibody, it targets the CD20 protein on B cells, thereby inhibiting the growth and survival of cancerous cells. Gazyva manufactured by Roche Bangladesh Ltd. In Bangladesh. Obinutuzumab is given by injection into a vein by a health care professional. It is given as directed by patient’s doctor, usually once certain days each month.

Gazyva side effects

The most common side effects of Obinutuzumab are: Infusion-related reactions, Fatigue, Nausea, Fever, Cough, Diarrhea, Anemia, Infections (e.g., respiratory, urinary), Thrombocytopenia, Neutropenia.

Originator brand

Gazyva by Genentech, Inc

Made by

Roche Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.